Introduction {#s1}
============

Colorectal cancer is one of the most frequently diagnosed cancers and a major cause of cancer deaths in Taiwan. [@pone.0068526-Huang1] The primary treatment is resection, and adjuvant treatment is needed in high-risk patients. [@pone.0068526-Chen1] Adjuvant treatment depends upon accurate staging. However, lymph node involvement is a highly important prognostic factor in colorectal cancer staging. [@pone.0068526-Leung1] The results of several studies have been used to define the minimum number of lymph nodes to be harvested for accurate staging. Berberoglu et al. reviewed T1-4N0M0 colorectal cancer patients and reported that when more than 11 lymph nodes are examined, staging is more accurate. [@pone.0068526-Berberoglu1] In 2007, the National Quality Forum endorsed the harvest of 12 lymph nodes as a standard quality indicator for colorectal cancer resection specimens. [@pone.0068526-Chou1] Therefore, lymph node yield during colorectal cancer surgery is being recommended as a benchmark of quality care. Recently, Chang et al. used propensity scoring to examine the number of lymph nodes harvested, and approved the number of lymph nodes as an indicator of quality of care. [@pone.0068526-Chang1] Chung et al. analyzed the core measures and indicated these can be developed systematically and applied to improve quality of care. [@pone.0068526-Chung1] However, despite these suggestions and guidelines, only 52% to 78% of hospitals comply. [@pone.0068526-Bilimoria1] Therefore, the objective of our study is to evaluate the impact of various factors upon, and identify independent associations with, lymph node harvest.

Materials and Methods {#s2}
=====================

Ethics Statement {#s2a}
----------------

The study protocol was approved by the Buddhist Dalin Tzu Chi General Hospital Institutional Review Board (B10102003). The institutional review board waived the need for written informed consent from the participants because the data released from the hospital database were analyzed anonymously.

Patient Population {#s2b}
------------------

The records of 166 patients with Stage I to Stage III colorectal cancer (TNM system) seen at one institution from August 2008 to June 2012 were reviewed. These patients received radical surgery as definitive therapy, and high-risk patients had adjuvant treatment. "High-risk factors" were defined as T3 or T4 lymph node involvement, or positive margins. All surgery was performed by colorectal specialists. Pathology data were obtained within 2 weeks after surgery. Pathology reports were reviewed to establish tumor size, grade, type, surgical margins, lymph nodes involved, perineural invasion, vascular permeation, lymphatic permeation, extracapsular spread (ECS), and specimen length. Other demographic data were recorded from electronic medical records and released from the hospital database. Four patients were excluded from the analysis because of loss to follow up (3 patients) or occurrence of a synchronous second primary (1 patient). All patients had colorectal cancer diagnosed histologically by pathologists and none had a prior history of cancer. All patients were informed about their disease treatment, including potential benefits and possible side effects, and were treated by multidisciplinary teams of colorectal surgeons, radiation oncologists, medical oncologists, and dieticians.

Statistical Analysis {#s2c}
--------------------

The subgroup analysis of lymph node yields was determined using a t-test and analysis of variants (ANOVA). In addition, a linear regression model and multivariable analysis were used to perform potential confounding and predicting variables. The appropriateness of the regression model was assessed by using influence-diagnostics-based leverage, studentized residuals and Cook's distance. The model was then rerun without advanced deviation values. [@pone.0068526-Nash1] SPSS 12.0 software (SPSS Inc, Chicago, IL, USA) was used for the analysis of all data. A statistically significant difference was defined as *P*\<0.05.

Results {#s3}
=======

Patient characteristics are presented in [Table 1](#pone-0068526-t001){ref-type="table"}. The mean age was 65.6 years (range: 28 to 90 years). When patients were grouped by diagnosis, there were 36, 70, and 56 patients in Stage I, Stage II and Stage III, respectively. More than half of the patients had laparoscopic resections. The mean specimen length was 17.86 cm (range: 6.7 to49.5 cm). In separate univariate analysis, tumor location, tumor size (dichotomized at 4 cm), specimen length (dichotomized at 13 cm), and the individual surgeon and pathologist had significant associations with lymph node yields ([Table 2](#pone-0068526-t002){ref-type="table"}). The distribution of lymph node count was approximately symmetrical and close to a normal distribution ([Figure 1](#pone-0068526-g001){ref-type="fig"}). The mean number of lymph nodes was 17, and the median was 15. These variables were then analyzed using a multiple linear regression model ([Table 3](#pone-0068526-t003){ref-type="table"}). After adjustment of other factors, five variables were significantly associated with lymph node yield. These were: tumor size, surgical method, specimen length, and surgeon and pathologist. The adjusted coefficient of determination (*R^2^*) was calculated to be 52.5% and 8.1% after removing significant variables. The explained value was 44.4% using these five significant variables.

![The distribution of lymph node count.](pone.0068526.g001){#pone-0068526-g001}

10.1371/journal.pone.0068526.t001

###### Descriptive statistics of patients, tumors and operative factors (n = 162).

![](pone.0068526.t001){#pone-0068526-t001-1}

  Variables of interest                    Mean or percent   Minimum-Maximum
  --------------------------------------- ----------------- -----------------
  Patient factors                                           
  Age (yr)                                      65.57            28--90
  Female gender                                  44%        
  Body mass index (kg/m^2^)                     24.06          15.1--33.7
  Tumor factors                                             
  T3/4                                           75%        
  Node-positive                                  35%        
  Poorly differentiated                          12%        
  Extracapsular spreading of lymph node          15%        
  Lymphatic permeation                           59%        
  Vascular permeation                            12%        
  Neural invasion                                20%        
  Proximal margin positive                       0%         
  Distal margin positive                         1%         
  Peritoneum positive                            12%        
  Tumor size (cm)                               4.48            0.4--15.0
  Location in colon                              47%        
  Operative factors                                         
  Laparoscopy                                    61%        
  Specimen length (cm)                          17.86           6.7--49.5

10.1371/journal.pone.0068526.t002

###### Lymph node yields by subgroup.

![](pone.0068526.t002){#pone-0068526-t002-2}

  Variable                               n    Lymph nodes (mean)    SD                   *P-*value
  ------------------------------------ ----- -------------------- ------ -----------------------------------------
  Patient factors                                                        
  Age (yr)                                                               
  ≦ 65                                  74           17.2          9.7                     0.74
  \>65                                  88           16.7          8.8   
  Gender                                                                 
  male                                  90           16.7          8.3                     0.69
  female                                72           17.3          10.3  
  Body mass index (kg/m^2^)                                              
  ≦ 28                                  140          16.7          9.6                     0.37
  \>28                                  22           18.6          5.7   
  Tumor factors                                                          
  Tumor location                                                         
  Colon                                 76           18.5          9.1                     0.04
  Rectal                                86           15.6          9.1   
  pT                                                                     
  1--2                                  40           15.1          11.6                    0.13
  3--4                                  122          17.6          8.2   
  pN                                                                     
  0                                     106          16.6          10.6                    0.56
  1--2                                  56           17.5          5.6   
  pStage                                                                 
  I                                     36           15.4          12.2                    0.52
  II                                    70           17.3          9.8   
  III                                   56           17.5          5.6   
  Differentiated                                                         
  Well/moderately                       143          17.1          9.5                     0.47
  Poorly                                19           15.5          6.4   
  Extracapsular spread of lymph node                                     
  Negative                              138          16.8          9.8                     0.72
  Positive                              24           17.6          4.9   
  Lymphatic permeation                                                   
  Negative                              66           16.7          9.3                     0.80
  Positive                              96           17.1          9.2   
  Vascular permeation                                                    
  Negative                              142          16.8          9.6                     0.59
  Positive                              20           18.0          5.2   
  Neural invasion                                                        
  Negative                              129          16.2          7.4                     0.15
  Positive                              33           19.9          14.0  
  Peritoneum                                                             
  Negative                              143          16.6          9.4                     0.18
  Positive                              19           19.6          7.4   
  Tumor size (cm)                                                        
  ≦ 4                                   79           13.9          5.9    \<0.05[\*](#nt101){ref-type="table-fn"}
  \>4                                   83           19.9          10.7  
  Operative factors                                                      
  OP method                                                              
  Laparoscopic resection                99           16.1          8.3                     0.14
  Open resection                        63           18.4          10.4  
  Specimen length (cm)                                                   
  ≦ 13                                  46           14.1          5.6     0.01[\*](#nt101){ref-type="table-fn"}
  \>13                                  116          18.1          10.0  
  Surgeon                                                                
  A                                     13           17.6          7.0     0.03[\*](#nt101){ref-type="table-fn"}
  B                                     27           21.7          12.7  
  C                                     122          15.8          8.1   
  Pathologist                                                            
  A                                     35           16.9          7.5    \<0.05[\*](#nt101){ref-type="table-fn"}
  B                                     37           26.0          4.4   
  C                                     57           15.8          6.7   
  D                                     33           13.6          5.4   

Statistically significant difference (*P*\<0.05).

10.1371/journal.pone.0068526.t003

###### Linear regression model of lymph node yield.

![](pone.0068526.t003){#pone-0068526-t003-3}

                             Variables of interest          Measure of effect   Standard error                  *P-*value
  ------------------- ------------------------------------ ------------------- ---------------- -----------------------------------------
  Patient factors                                                                               
                                    Age (yr)                      −0.54              0.04                         0.15
                                     Gender                       0.94               0.93                         0.31
                           Body mass index (kg/m^2^)              −0.05              0.13                         0.73
  Tumor factors                                                                                 
                                    T-stage                       0.79               0.88                         0.37
                          Total lymph node metastasis             0.29               0.22                         0.18
                                 Differentiated                   −0.04              1.35                         0.98
                       Extracapsular spread to lymph node         −1.12              1.73                         0.52
                              Lymphatic permeation                0.47               1.03                         0.65
                              Vascular permeation                 −0.29              1.38                         0.83
                                Neural invasion                   −1.60              1.40                         0.26
                                   Peritoneum                     2.31               1.79                         0.20
                                Tumor size (cm)                   1.25               0.28        \<0.05[\*](#nt102){ref-type="table-fn"}
                                 Tumor location                   −1.38              0.94                         0.14
  Operative factors                                                                             
                                Surgical method                   −2.95              1.23         0.02[\*](#nt102){ref-type="table-fn"}
                                Specimen length                   0.17               0.08         0.03[\*](#nt102){ref-type="table-fn"}
                                    Surgeon                       3.54               1.64        \<0.05[\*](#nt102){ref-type="table-fn"}
                                  Pathologist                     4.91               2.05        \<0.05[\*](#nt102){ref-type="table-fn"}

Statistically significant difference (*P*\<0.05).

Discussion {#s4}
==========

The most important issue in a postoperative setting is accurate staging, particularly nodal staging. Survival is associated with an increasing number of lymph nodes analyzed. [@pone.0068526-LeVoyer1] In addition, the number of involved lymph nodes has been reported to be positively correlated with the number of lymph nodes examined. [@pone.0068526-Thorn1].

How to obtain adequate lymph nodes remains an important issue in colorectal cancer. In our study, we found that tumor size, surgical method, specimen length, and the individual surgeon and pathologist were significantly associated with lymph node yields.

Surgical variables influence the number of lymph node retrieved. The most important issue is the behavior of surgeons. Nicholl et al. reported that mean nodal yield increased among fellowship-trained surgeons and non-fellowship-trained surgeons alike. [@pone.0068526-Nicholl1] The results of another study also demonstrated that advanced fellowship training of surgeons could increase lymph node yield. [@pone.0068526-Barbas1] In our study, the surgical approach and the individual surgeon were significantly associated with lymph node yields. However, the surgical method is dependent upon surgeon ability. Although patients and tumor characteristics are important factors in lymph node yields, they are only partly responsible for the variation. Quality of surgical resection may explain the variance proportion. Adequate training, to improve lymph node harvest, could improve the quality of cancer care.

Variances among pathologists were as striking as those among surgeons. When Mekenkamp et al. selected patients from a multicenter prospective randomized trial, they found great variations between pathology laboratories and individual pathologists. [@pone.0068526-Mekenkamp1] Some studies reported the importance of the use of fat solvents or optimal specimen fixation. [@pone.0068526-Storli1], [@pone.0068526-Svec1] Pathologists should have a standardized pathology procedure for lymph node harvesting. Storli et al. used a questionnaire to examine ways different institutions handled colon cancer specimens and found variations in the routines of each department. [@pone.0068526-Storli1] However, variations existed even within a single institution. A standardized pathology guideline is essential because optimal tissue handling can improve assessment outcome.

Tumor characteristics also influenced lymph node yields. Larger tumors may be more visible on pathologic examination due to increased cancer antigen and inflammation response. [@pone.0068526-Wright1] Chou et al showed that with every 1-cm increase in tumor size, there was an average increase of 2% to 3% in the number of lymph nodes examined in colorectal cancer specimens. [@pone.0068526-Chou1] Nash et al. observed an increase in average lymph nodes yields among T3/T4 tumors versus T0--T2 tumors. [@pone.0068526-Nash1] In our study, tumors larger than 4 cm had more lymph node yields than did smaller tumors. In addition, tumor size has been shown to be a more important predictor of lymph node yield than is tumor stage. [@pone.0068526-Nash1].

The results of our study also indicated that the other positive predictor of lymph node retrieval, after multivariate analysis, was specimen length. Specimen length correlated positively with the number of nodes retrieved, by linear regression analysis, and the dichotomized length which regarded lymph node yields was 13 cm. Similar to our results, Norwood et al. demonstrated that a longer specimen length results in a higher lymph node retrieval rate. [@pone.0068526-Norwood1] In another study, the anatomic site of the tumor influenced the number of lymph node examination and decreased lymph node retrieval with distal tumor. [@pone.0068526-Baxter1] This may help to explain why longer anatomical specimens, such as those from an extended right hemicolectomy, have relatively higher nodal yields. [@pone.0068526-Norwood1] Interestingly, Nash et al. further demonstrated that measuring the extent of mesenteric resection using the number of vascular pedicles was a significant predictor of lymph node yield, independent of the length of bowel resected. [@pone.0068526-Nash1].

In our study, five variables were significantly associated with lymph node yield. They were tumor size, surgical method, specimen length, and surgeon and pathologist. From literature reviews, factors significantly affecting the lymph node yields among different hospitals may be different. [@pone.0068526-Sarli1] For improving lymph node yield in our hospital, we try to propose strategies. The efforts included regular cancer treatment combine meeting that surgeons and pathologists could mutual communicate. Furthermore, the consensus of adequate training for surgical quality and a standardized procedure for specimen handled were also obtained. These methods could help to improve cancer care. We also suggest that every hospital should review own results to adhere a benchmark of quality care and find out the factors that can be improved by specific strategies.

Conclusions {#s4a}
-----------

Patients, tumor characteristics and surgical variables influence the number of lymph nodes retrieved. Physicians are the main gatekeepers. Adequate training and optimized guidelines could greatly improve the quality of lymph node yields.
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